Mood & Mental Health

·

Study

Psychedelics May Relieve Long COVID Symptoms

Psychedelics May Relieve Long COVID Symptoms

Psilocybin mushrooms

What they found

A case study suggests psilocybin and MDMA may ease Long COVID neurological and mental health symptoms.

A case study suggests psilocybin and MDMA may ease Long COVID neurological and mental health symptoms.

How solid is it?

Early human

Early human

Human – case report

Human – case report

Evidence ladder: Lab dish → Animal → Early human → Strong human. Reviews summarize earlier research.

At a glance

Latin name

Compound

psilocybin; MDMA

psilocybin; MDMA

Published in

Shroomer

Shroomer

Covered in Shroom Scan

Section

2024 RECAP

2024 RECAP

As it ran in Shroom Scan

Psilocybin & Long COVID Relief

Psilocybin & Long COVID Relief

A new case study suggests psilocybin and MDMA may help alleviate neurological and mental health symptoms of Long COVID, such as anxiety and depression. Psychedelics’ ability to create new neural pathways and reduce inflammation shows potential, but broader research is needed. With no current catch-all treatment for Long COVID, this finding sparks hope for future therapeutic options.

A new case study suggests psilocybin and MDMA may help alleviate neurological and mental health symptoms of Long COVID, such as anxiety and depression. Psychedelics’ ability to create new neural pathways and reduce inflammation shows potential, but broader research is needed. With no current catch-all treatment for Long COVID, this finding sparks hope for future therapeutic options.

Depression & Dementia Research and Mushroom Supplement Quality Guide

Read the original study ↗

Get Shroom Scan

Next study

Spiritus Oregon Becomes First Legal Psilocybin Edible Company ›

Shroom Scan · Every Friday

Get Studies Like This, Translated, Every Week

Ten new studies a week, each boiled down to what it found and why it matters to you. Free, and one click to leave.

See what's inside →